Mentoring program supports industry–academia collaboration
- Paulina Toboła joins the “Siła Wspólnoty” mentoring program at Lodz University of Technology. She will support 2 mentees with her experience in analytics development in biopharma.
- The mentoring program creates an environment conducive to development, mutual support, and inspiration.
- Mabion supports industry–academia collaboration and develop young talent. Mentoring is one of the most valuable forms of development – based on dialogue, trust, and partnerships.
Mentoring program connecting business and science
The “Siła Wspólnoty” (en. Power of Community) mentoring program connects students of Lodz University of Technology with experienced alumni. Its goal is knowledge exchange and long-term cooperation. It also helps students plan their professional paths with confidence.
The second edition of the program was officially inaugurated on January 21st at Lodz University of Technology. The event brought together mentors, mentees, university authorities, and faculty representatives. The Rector of Lodz University of Technology, Professor Krzysztof Jóźwik, highlighted the role of alumni in supporting future generations.
The program shows that the university community does not end with a diploma. Alumni return with their experience and share it in a natural way. Students gain access to practical insights and real career stories. Mentoring is based on dialogue, trust, and partnership.
This initiative is supported by a strong local ecosystem in Łódź. The City Council, Invest in Lodz, the Lodz Agency of Regional Development, the Łódź Akademicka Foundation, and the Lodz Special Economic Zone all support talent development. Programs such as “Młodzi w Łodzi” create space for young people to grow. Together, they build a friendly environment for students and graduates.
Build your career in biotech and pharma
The mentoring program creates an environment conducive to development, mutual support, and inspiration. The biopharma sector is open to cooperation with universities. It values scientific knowledge and fresh perspectives. Students can see how theory becomes real products and processes.
Biotechnology and biochemistry play a key role in modern drug development. Analytics, quality control, and process development are essential areas. Molecular biology and pharmacy graduates also find many development paths. Work often involves advanced technologies and regulated environments. Learning never stops, and knowledge transfer is part of daily work. These fields require curiosity, precision, and teamwork.
Industry–academia collaboration helps students understand real biopharma challenges. Mabion actively supports young talent entering biotech and pharma. We believe in cooperation with academia and mentoring initiatives. Students and graduates interested in joining our teams can visit the Careers tab on our website to learn more.
Our mission is to ensure that new biological drugs are developed in full compliance with global regulatory standards, enabling their safe introduction to the market.
Paulina Toboła’s Career Path
Paulina is a specialist and manager with over 8 years of experience in the key sector of biotechnology and biopharmaceuticals. As Analytics Development Division Manager at Mabion, she leads a team of several people.
Paulina’s career path is a practical example of how to combine science with industry. She has applied the knowledge she gained during her studies, including at RWTH Aachen University (Erasmus+) and during internships (UNESP Botucatu), in projects of global significance. She has participated in the technology transfer process and work on the production of the COVID-19 vaccine and in the creation of biosimilar drugs. She also represents the company at trade fairs (CPHI 2025, Festival of Biologics 2025 and BIO International Convention 2025) and is the author of numerous scientific articles published by Outsourced Pharma and Biosimilar Development, among others.
Paulina’s passion is team development. Since 2020, she has been consciously investing in her leadership skills, as confirmed by her completion of the Leader Academy (an internal, year-long project at Mabion) and the Manager Academy (EY). This knowledge allows her to support talent and build strong teams.
Under Paulina’s watchful eye, Patrycja Grabarczyk and Konrad Stefaniak will develop their skills in the program. In 2025, Patrycja participated in the E2TOP program, conducting her research on insulin aggregation inhibitors in the treatment of neurodegenerative diseases under the supervision of Prof. Beata Kolesińska. Meanwhile, Konrad received an award from the Polish Union of Plastics Converters for his engineering thesis “Modification of ENR/PLA biocomposites using natural anti-aging substances”. He also participated in an earlier edition of the E2TOP program, working on poly(lactic acid) composites with plant-based additives under the supervision of Prof. Anna Masek. Together with his supervisor, he also published several scientific articles.
Prepared by:
Marketing Specialist
Sources
- CPHI personal stories roundtable. 24/7 Biopharma. 2025; 28-29.
- Małecka A, Toboła P. Does Your CDMO Have An Analytical Edge? Outsourced Pharma. 2024.
- Miłek P, Toboła P, Tuszyner A. Impact Of Glycosylation On The Effector Functions Of Monoclonal Antibodies: A Case Study Of Rituximab. Biosimilar Development. 2024.
- Chojnacka E. „Siła Wspólnoty” ponownie połączyła pokolenia. Życie Uczelni nr 175. Politechnika Łódzka. 2025.
- Chojnacka E. Program, który jest nieoceniony. Życie Uczelni nr 171. Politechnika Łódzka. 2025.
- Tworzywa.org, PZPTS: Konrad Stefaniak’s work was awarded. 2024.